Partnering Solutions

  1. Biorasi Rare and Urgent Disease 9/21/2021

    Read how Biorasi's speed and agility make all the difference in overcoming unique obstacles to rare disease clinical trials.

  2. Pandemic Response Assessment 8/9/2021

    In the face of the COVID-19 pandemic, biopharmaceutical companies had to react quickly to develop and implement what were frequently large scale crisis response initiatives. Read how now is the time to assess the changes that were implemented and refine business continuity plans to ensure regulatory compliance, patient safety, and organizational preparedness now and into the future.

  3. Integrated Programs To Bridge Molecules From Discovery Into Clinical Development 1/4/2023

    A new collaboration helps to remove obstacles from the critical path, reduce development risks, eliminate the white space in pre-clinical drug development, and shorten the pathway to clinical development.

  4. How Biorasi Optimizes Clinical Solutions 4/26/2019

    Best-in-class processes coupled with industry-leading technology to fight for your trial’s success.

  5. Suvoda Scheduling 10/23/2025

    Making it easier to participate in and run clinical trials with simplified patient scheduling and appointment reminders.

  6. Data Licensing For Clinical Trial Planning 2/21/2025

    Quest Diagnostics' data licensing solutions enhance clinical trial planning by optimizing site selection, investigator identification, and regulatory compliance.

  7. Balancing The Scales: The Strategic Role Of Stipends In Trial Success 5/17/2024

    Traditional clinical trial models can create financial burden by neglecting participant needs – but effective use of stipends can allow participants to fully engage without financial worries.

  8. Integrated CRO Services 1/26/2023

    With over 30 years of experience, Altasceinces delivers customized and scalable CRO services purpose-built for early-phase to Phase Ib/IIa development.

  9. Isotope Labelling 3/3/2022

    Whether you need isotopically labelled (14C/SIL) compounds for nonclinical or clinical metabolism studies and the quantification of materials in biological matrices, our expertise provides the necessary labelled materials tailored to support your studies.

  10. Accelerate Your Clinical Development Program With Novotech 9/29/2022

    Novotech delivers unmatched experience as the Asia-Pacific’s leading CRO with 11 dedicated offices, expert teams and deep local regulatory knowledge.